Archive for January, 2013

BIT C2 Diagnostics Adds Hematology Competence Center

BIT C2 Diagnostics is a leader in development, design, manufacture and support of custom Hematology instrumentation. In response to recent growth, demand and internal initiatives to interface more…(PRWeb January 29, 2013)Read the full story at htt…

NSG Precision Has Perfected the Wavelength Accuracy Calibration…

NSG Precision Cells has been tirelessly working for 50 years and still continues to exceed customers’ expectations. With its new solid-state UV/VIS spectrophotometer…

(PRWeb January 29, 2013)

Read the full story at

Idem Translations Achieves EN 15038:2006 Certification

Idem Translations achieves EN 15038:2006 Certification and follows the best practices model designed exclusively for the translation industry(PRWeb January 29, 2013)Read the full story at

Migraines Found Linked to Nighttime Teeth Grinding & Clenching in…

Study indicates migraines can be completely eliminated for majority of TMJ disorder sufferers by reducing nighttime teeth grinding and clenching…(PRWeb January 29, 2013)Read the full story at…

SPIE Leaders Urge Photonics Community to Assert Need for Full Horizon…

Industry and researchers in the photonics sector need to let their MEPs know just how vital the proposed Horizon 2020 research programme is to ensuring a strong future for Europe, say leaders of SPIE,…(PRWeb January 28, 2013)Read the full story at…

Drug Patent Expirations for Jan 9 2013

If your reader cannot render the information below, go to to see the latest expirations


This newsletter is
a free service of DrugPatentWatch

DrugPatentWatch offers comprehensive details on FDA approved drugs,
developers, and their patents

Drug Patent Expirations for January 9 2013

Tradename Applicant Generic Name Patent
ACCOLATE Astrazeneca zafirlukast Jan 9, 2013

*Drugs may be
covered by multiple patents or regulatory protections. See the DrugPatentWatch
database for complete details.


Which pharmaceutical companies recieved the most drug approvals last

Most Drug Approvals Last

infographics &raquo

DrugPatentWatch Serves Your Competitive Intelligence

Subscribers have
access to valuable datasets, including:
  • Patent litigation
  • Clinical trial information
  • International patent families
  • International patent priority and PCT
  • Patent maintenance
  • Full-text patent downloads
  • Sales data (top 200 drugs)
  • Paragraph IV challenges
  • Tentative approvals
  • Drug Master Files
  • Dynamic search capabilities with data
  • More…
See the Database
and Plan
. Contact Us with any

The above list
does not discriminate between dominant and non-dominant patents. Drugs
listed above may be protected by additional patents and other regulatory
protections. See the DrugPatentWatch
database for complete details

Although great care is taken in the proper and correct provision of this
service, thinkBiotech LLC does not accept any responsibility for possible
consequences of errors or omissions in the provided information. There is
no warranty that the information contained herein is error free. Users of
this service are advised to seek professional advice and independent
confirmation before acting on any of the provided information. thinkBiotech
LLC reserves the right to amend, extend or withdraw any part or all of the
offered service without notice.
All trademarks and applicant names
are the property of their respective owners or